| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | A synthesized peptide derived from human Receptor interacting serine threonine kinase 2 was used as the immunogen for the RIPK2 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
RIPK2 Antibody / Receptor interacting serine threonine kinase 2 is a anti-RIPK2 Rabbit antibody Recombinant Rabbit Monoclonal clone 31R02 supplied in Liquid format. Recommended for workflows such as Western blot (WB) with listed reactivity in Human, Mouse, Rat.
Key elements and design rationale
- Target: RIPK2
- Antibody details: Rabbit, Recombinant Rabbit Monoclonal, clone 31R02, isotype Rabbit IgG
- Format: Liquid
- Applications (as listed): WB
Biological background
Receptor interacting serine threonine kinase 2 is activated by NOD1 and NOD2, intracellular pattern recognition receptors that detect bacterial peptidoglycan. Upon ligand recognition, NOD proteins recruit RIPK2 through caspase activation and recruitment domains, leading to kinase activation and signaling complex formation. Research using RIPK2 antibody has shown that this kinase is indispensable for NF kappa B activation, cytokine production, and antimicrobial defense. By functioning as a central signaling hub, RIPK2 links bacterial detection to adaptive immune responses.
Beyond antimicrobial defense, RIPK2 contributes to autophagy and regulation of cell death. Studies with RIPK2 antibody have demonstrated that it interacts with autophagy proteins to clear intracellular bacteria. Dysregulation of RIPK2 signaling can lead to pathological inflammation, contributing to Crohn disease, Blau syndrome, and other autoinflammatory conditions. Mutations in RIPK2 or its upstream activators alter immune responses and are associated with susceptibility to chronic inflammatory disease.
In oncology, aberrant RIPK2 activation has been linked to tumor progression and immune evasion. Research with RIPK2 antibody has revealed that overexpression or hyperactivation of this kinase promotes survival pathways in cancer cells and contributes to a proinflammatory tumor microenvironment. Inhibition of RIPK2 is being investigated as a therapeutic strategy to reduce chronic inflammation and enhance cancer immunotherapy outcomes.
RIPK2 antibody is widely used in western blotting, immunohistochemistry, and immunoprecipitation. Western blotting demonstrates phosphorylation dependent activation, immunohistochemistry highlights expression in inflamed tissues, and immunoprecipitation isolates complexes formed during NOD signaling. These applications make RIPK2 antibody a versatile reagent for both basic and translational immunology.
By supplying validated RIPK2 antibody reagents,
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Monoclonal antibodies provide a defined epitope recognition profile that can support consistent comparisons across experiments.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
